Mineralocorticoid receptor signaling: crosstalk with membrane receptors and other modulators.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Steroids

• Publication date

  2014-12-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.steroids.2014.05.017PMID 24928729
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation.

  2013cited by this paper
• Mineralocorticoid receptor antagonism attenuates experimental pulmonary hypertension.

  2013cited by this paper
• Mineralocorticoid receptor phosphorylation regulates ligand binding and renal response to volume depletion and hyperkalemia.

  2013cited by this paper
• Aldosterone stimulates fibronectin synthesis in renal fibroblasts through mineralocorticoid receptor-dependent and independent mechanisms.

  2013cited by this paper
• Mineralocorticoid Receptor–Mediated Vascular Insulin Resistance

  2013cited by this paper
• Histone Deacetylase Inhibition Attenuates Transcriptional Activity of Mineralocorticoid Receptor Through Its Acetylation and Prevents Development of Hypertension

  2013cited by this paper
• Aldosterone increases cardiac vagal tone via G protein‐coupled oestrogen receptor activation

  2013cited by this paper
• Mineralocorticoid receptor interaction with SP1 generates a new response element for pathophysiologically relevant gene expression

  2013cited by this paper
• Cross-talk between mineralocorticoid receptor/angiotensin II type 1 receptor and mitogen-activated protein kinase pathways underlies aldosterone-induced atrial fibrotic responses in HL-1 cardiomyocytes.

  2013cited by this paper
• Novel tyrosine kinase signaling pathways: implications in vascular remodeling

  2012cited by this paper
• The phosphatase calcineurin PP2BAβ mediates part of mineralocorticoid receptor transcriptional activity

  2012cited by this paper
• The Epidermal Growth Factor Receptor Is Involved in Angiotensin II But Not Aldosterone/Salt-Induced Cardiac Remodelling

  2012cited by this paper
• Aldosterone Induces Kidney Fibroblast Proliferation via Activation of Growth Factor Receptors and PI3K/MAPK Signalling

  2012cited by this paper
• Signaling of Receptor Tyrosine Kinases in the Nucleus

  2012cited by this paper
• Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury

  2012cited by this paper
• Aldosterone inhibits endothelial morphogenesis and angiogenesis through the downregulation of vascular endothelial growth factor receptor-2 expression subsequent to peroxisome proliferator-activated receptor gamma.

  2012cited by this paper
• EGFR signaling promotes TGFβ-dependent renal fibrosis.

  2012cited by this paper
• Angiotensin II-aldosterone interaction in human coronary microarteries involves GPR30, EGFR, and endothelial NO synthase.

  2012cited by this paper
• Aldosterone Induces Vascular Insulin Resistance by Increasing Insulin-Like Growth Factor-1 Receptor and Hybrid Receptor

  2012cited by this paper
• Differential ubiquitylation of the mineralocorticoid receptor is regulated by phosphorylation

  2012cited by this paper
• Modulation of transcriptional mineralocorticoid receptor activity by nitrosative stress.

  2012cited by this paper
• Oxidative Stress Causes Mineralocorticoid Receptor Activation in Rat Cardiomyocytes: Role of Small GTPase Rac1

  2012cited by this paper
• Hyperaldosteronism is associated with a decrease in number and altered growth factor expression of endothelial progenitor cells in rats.

  2011cited by this paper
• Vascular proinflammatory responses by aldosterone are mediated via c-Src trafficking to cholesterol-rich microdomains: role of PDGFR.

  2011cited by this paper
• Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway.

  2011cited by this paper
• Aldosterone Stimulates the Cardiac Na+/H+ Exchanger via Transactivation of the Epidermal Growth Factor Receptor

  2011cited by this paper
• Epidermal Growth Factor Receptor Mediates the Vascular Dysfunction But Not the Remodeling Induced by Aldosterone/Salt

  2011cited by this paper
• GPR30 Expression Is Required for the Mineralocorticoid Receptor–Independent Rapid Vascular Effects of Aldosterone

  2011cited by this paper
• Interaction between mineralocorticoid receptor and cAMP/CREB signaling.

  2010cited by this paper
• Aldosterone enhances IGF-I-mediated signaling and biological function in vascular smooth muscle cells.

  2010cited by this paper
• Aldosterone and inflammation

  2010cited by this paper
• Antifibrotic activity of an inhibitor of histone deacetylases in DOCA‐salt hypertensive rats

  2010cited by this paper
• HDAC Inhibition Attenuates Inflammatory, Hypertrophic, and Hypertensive Responses in Spontaneously Hypertensive Rats

  2010cited by this paper
• Mineralocorticoid receptor inhibits CREB signaling by calcineurin activation

  2010cited by this paper
• Elevated Mineralocorticoid Receptor Activity in Aged Rat Vascular Smooth Muscle Cells Promotes a Proinflammatory Phenotype via Extracellular Signal-Regulated Kinase 1/2 Mitogen-Activated Protein Kinase and Epidermal Growth Factor Receptor–Dependent Pathways

  2010cited by this paper
• Placental growth factor mediates aldosterone-dependent vascular injury in mice.

  2010cited by this paper
• Mineralocorticoid receptor degradation is promoted by Hsp90 inhibition and the ubiquitin-protein ligase CHIP.

  2010cited by this paper
• Protein kinase D stabilizes aldosterone-induced ERK1/2 MAP kinase activation in M1 renal cortical collecting duct cells to promote cell proliferation.

  2010cited by this paper
• Stimulation of Platelet-derived Growth Factor Receptor β (PDGFRβ) Activates ADAM17 and Promotes Metalloproteinase-dependent Cross-talk between the PDGFRβ and Epidermal Growth Factor Receptor (EGFR) Signaling Pathways*

  2010cited by this paper
• Aldosterone inhibits insulin-induced glucose uptake by degradation of insulin receptor substrate (IRS) 1 and IRS2 via a reactive oxygen species-mediated pathway in 3T3-L1 adipocytes.

  2009cited by this paper
• Aldosterone Promotes Fibronectin Synthesis in Rat Mesangial Cells via ERK1/2-Stimulated Na+-H+ Exchanger Isoform 1

  2009cited by this paper
• Osmotic stress regulates mineralocorticoid receptor expression in a novel aldosterone-sensitive cortical collecting duct cell line.

  2009cited by this paper
• Aldosterone up‐regulates 12‐ and 15‐lipoxygenase expression and LDL oxidation in human vascular smooth muscle cells

  2009cited by this paper
• New aspects of rapid aldosterone signaling.

  2009cited by this paper
• Cardiac aldosterone overexpression prevents harmful effects of diabetes in the mouse heart by preserving capillary density

  2009cited by this paper
• Mineralocorticoid receptor antagonism attenuates glomerular filtration barrier remodeling in the transgenic Ren2 rat.

  2009cited by this paper
• Aldosterone-induced mesangial cell proliferation is mediated by EGF receptor transactivation.

  2009cited by this paper
• The role of mineralocorticoid receptor expression in brain remodeling after cerebral ischemia.

  2008cited by this paper
• Immediate Mineralocorticoid Receptor Blockade Improves Myocardial Infarct Healing by Modulation of the Inflammatory Response

  2008cited by this paper
• Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation

  2008cited by this paper
• Aldosterone regulates rapid trafficking of epithelial sodium channel subunits in renal cortical collecting duct cells via protein kinase D activation.

  2008cited by this paper
• Aldosterone and Angiotensin II Synergistically Stimulate Migration in Vascular Smooth Muscle Cells Through c-Src–Regulated Redox-Sensitive RhoA Pathways

  2008cited by this paper
• Cross-Talk Between Mineralocorticoid and Angiotensin II Signaling for Cardiac Remodeling

  2008cited by this paper
• EF Domains Are Sufficient for Nongenomic Mineralocorticoid Receptor Actions*

  2008cited by this paper
• New insights on signaling cascades induced by cross-talk between angiotensin II and aldosterone

  2008cited by this paper
• Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease

  2008cited by this paper
• Targeting of RhoA/ROCK Signaling Ameliorates Progression of Diabetic Nephropathy Independent of Glucose Control

  2008cited by this paper
• Low-dose spironolactone reduces reactive oxygen species generation and improves insulin-stimulated glucose transport in skeletal muscle in the TG(mRen2)27 rat.

  2008cited by this paper
• Vasoconstrictor effect of aldosterone via angiotensin II type 1 (AT1) receptor: possible role of AT1 receptor dimerization.

  2008cited by this paper
• Pretreatment with eplerenone reduces stroke volume in mouse middle cerebral artery occlusion model.

  2007cited by this paper
• The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology

  2007cited by this paper
• Altered collagen homeostasis in human aortic smooth muscle cells (HAoSMCs) induced by aldosterone

  2007cited by this paper
• Aldosterone-induced EGFR expression: interaction between the human mineralocorticoid receptor and the human EGFR promoter.

  2007cited by this paper
• Antagonistic effects of bone morphogenetic protein-4 and -7 on renal mesangial cell proliferation induced by aldosterone through MAPK activation.

  2007cited by this paper
• Aldosterone rapidly activates protein kinase D via a mineralocorticoid receptor/EGFR trans-activation pathway in the M1 kidney CCD cell line.

  2007cited by this paper
• Direct binding and activation of protein kinase C isoforms by aldosterone and 17beta-estradiol.

  2007cited by this paper
• Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence.

  2007cited by this paper
• Plasma sodium stiffens vascular endothelium and reduces nitric oxide release

  2007cited by this paper
• IGF-1 vs insulin: respective roles in modulating sodium transport via the PI-3 kinase/Sgk1 pathway in a cortical collecting duct cell line.

  2007cited by this paper
• Transactivation of the IGF-1R by aldosterone.

  2007cited by this paper
• Aldosterone Suppresses Insulin Signaling Via the Downregulation of Insulin Receptor Substrate-1 in Vascular Smooth Muscle Cells

  2007cited by this paper
• Eplerenone With Valsartan Effectively Reduces Atherosclerotic Lesion by Attenuation of Oxidative Stress and Inflammation

  2006cited by this paper
• Mineralocorticoid Receptor Activation Causes Cerebral Vessel Remodeling and Exacerbates the Damage Caused by Cerebral Ischemia

  2006cited by this paper
• Angiotensin II-Induced Hypertension and Subsequent Renal Pathology is Attenuated in Mice Lacking Soluble Epoxide Hydrolase: P31

  2006cited by this paper
• Platelet-derived growth factor-BB transactivates the fibroblast growth factor receptor to induce proliferation in human smooth muscle cells.

  2006cited by this paper
• Aldosterone Impairs Bone Marrow–Derived Progenitor Cell Formation

  2006cited by this paper
• Aldosterone Stimulates Activity and Surface Expression of NHE3 in Human Primary Proximal Tubule Epithelial Cells (RPTEC)

  2006cited by this paper
• Rapid actions of aldosterone in vascular health and disease--friend or foe?

  2006cited by this paper
• ANG II-induced cardiac molecular and cellular events: role of aldosterone.

  2006cited by this paper
• Epidermal growth factor induces vasoconstriction through the phosphatidylinositol 3-kinase-mediated mitogen-activated protein kinase pathway in hypertensive rats.

  2006cited by this paper
• Involvements of Rho-kinase and TGF-beta pathways in aldosterone-induced renal injury.

  2006cited by this paper
• Aldosterone Stimulates Vascular Smooth Muscle Cell Proliferation Via Big Mitogen-Activated Protein Kinase 1 Activation

  2005cited by this paper
• Aldosterone Stimulates Collagen Gene Expression and Synthesis Via Activation of ERK1/2 in Rat Renal Fibroblasts

  2005cited by this paper
• Human mineralocorticoid receptor expression renders cells responsive for nongenotropic aldosterone actions.

  2005cited by this paper
• Angiotensin II and Aldosterone Regulate Gene Transcription Via Functional Mineralocortocoid Receptors in Human Coronary Artery Smooth Muscle Cells

  2005cited by this paper
• Aldosterone Activates Vascular p38MAP Kinase and NADPH Oxidase Via c-Src

  2005cited by this paper
• Cardioprotective Mechanisms of Spironolactone Associated with the Angiotensin-Converting Enzyme/Epidermal Growth Factor Receptor/Extracellular Signal-Regulated Kinases, NAD(P)H Oxidase/Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1, and Rho-Kinase Pathways in Aldosterone/Salt-Induced Hypert

  2005cited by this paper
• Aldosterone Synthase Inhibitor Ameliorates Angiotensin II–Induced Organ Damage

  2005cited by this paper
• Involvement of Aldosterone and Mineralocorticoid Receptors in Rat Mesangial Cell Proliferation and Deformability

  2005cited by this paper
• The nongenomic actions of aldosterone.

  2005cited by this paper
• Aldosterone and Angiotensin II Synergistically Induce Mitogenic Response in Vascular Smooth Muscle Cells

  2005cited by this paper
• Aldosterone stimulates proliferation of mesangial cells by activating mitogen-activated protein kinase 1/2, cyclin D1, and cyclin A.

  2005cited by this paper
• Endothelium-Derived Nitric Oxide Modulates Vascular Action of Aldosterone in Renal Arteriole

  2004cited by this paper
• Rapid, nongenomic effects of aldosterone in the heart mediated by epsilon protein kinase C.

  2004cited by this paper
• Mineralocorticoid receptor antagonists do not block rapid ERK activation by aldosterone.

  2004cited by this paper
• Proteasome‐Mediated Mineralocorticoid Receptor Degradation Attenuates Transcriptional Response to Aldosterone

  2004cited by this paper
• Aldosterone Administration to Mice Stimulates Macrophage NADPH Oxidase and Increases Atherosclerosis Development: A Possible Role for Angiotensin-Converting Enzyme and the Receptors or Angiotensin II and Aldosterone

  2004cited by this paper
• Aldosterone Potentiates Angiotensin II–Induced Signaling in Vascular Smooth Muscle Cells

  2004cited by this paper
• Tissue angiotensin II in the regulation of inflammatory and fibrogenic components of repair in the rat heart.

  2004cited by this paper
• Aldosterone Enhances Ischemia-Induced Neovascularization Through Angiotensin II–Dependent Pathway

  2004cited by this paper

• CD148 agonistic antibody alleviates renal injury induced by chronic angiotensin II infusion in mice

  2025cites this paper
• Mineralocorticoid receptor inhibition in parietal epithelial cells prevents focal segmental glomerulosclerosis and crescentic glomerulonephritis.

  2025cites this paper
• An Emerging Role for Gut-Brain Signaling Involving Ghrelin in Chronic Stress.

  2025cites this paper
• Eplerenone, a mineralocorticoid receptor inhibitor, reduces cirrhosis associated changes of hepatocyte glucose and lipid metabolism

  2024cites this paper
• Literature-Based Discovery to Elucidate the Biological Links between Resistant Hypertension and COVID-19

  2023cites this paper
• Themed Issue: Emerging Fields for Therapeutic Targeting of the Aldosterone-Mineralocorticoid Receptor Signaling Pathway

  2022cites this paper
• Non-genomic steroid signaling through the mineralocorticoid receptor: Involvement of a membrane-associated receptor?

  2021cites this paper
• The Interface of Nuclear and Membrane Steroid Signaling

  2021cites this paper
• Anthracycline-induced cardiotoxicity and renin-angiotensin-aldosterone system—from molecular mechanisms to therapeutic applications

  2020cites this paper
• Role of Estrogen Receptors in Modulating Aldosterone Biosynthesis And Blood Pressure.

  2019cites this paper
• Rapid actions of aldosterone revisited: Receptors in the limelight.

  2018cites this paper
• Diverging effects of enalapril or eplerenone in primary prevention against doxorubicin-induced cardiotoxicity

  2018cites this paper
• The selective mineralocorticoid receptor antagonist eplerenone prevents decompensation of the liver in cirrhosis

  2018cites this paper
• Aldosterone downregulates delayed rectifier potassium currents through an angiotensin type 1 receptor-dependent mechanism.

  2018cites this paper
• Role of Renin-Angiotensin-Aldosterone System Activation in Promoting Cardiovascular Fibrosis and Stiffness

  2018cites this paper
• Mechanisms of Action of Dehydroepiandrosterone.

  2018cites this paper
• Interaction of the Mineralocorticoid Receptor With RACK1 and Its Role in Aldosterone Signaling

  2017influential citation
• Genomic and Non-genomic Aldosterone

  2017cites this paper
• A Cardiac Mouse Model for Nongenomic Mineralocorticoid Receptor Effects

  2017cites this paper
• EGFR transactivation: mechanisms, pathophysiology and potential therapies in cardiovascular system

  2017cites this paper
• Third-generation Mineralocorticoid Receptor Antagonists: Why Do We Need a Fourth?

  2016cites this paper
• Corticosteroids Are Essential for Maintaining Cardiovascular Function in Male Mice.

  2016cites this paper
• Epidermal Growth Factor Receptor Transactivation: Mechanisms, Pathophysiology, and Potential Therapies in the Cardiovascular System.

  2016cites this paper
• Renin-Angiotensin-Aldosterone System: A Current Drug Target for the Management of Neuropathic Pain.

  2016cites this paper
• Novel mechanisms for DHEA action.

  2016cites this paper
• Stimulatory actions of IGF-I are mediated by IGF-IR cross-talk with GPER and DDR1 in mesothelioma and lung cancer cells

  2016cites this paper
• Does mineralocorticoid receptor play a vital role in the development of depressive disorder?

  2016cites this paper
• Hypothalamic-Pituitary--Adrenal Axis-Feedback Control.

  2015cites this paper
• Mechanisms of action of 5α- tetrahydrocorticosterone, a novel anti-inflammatory glucocorticoid

  2015cites this paper
• Mineralocorticoid receptor suppresses cancer progression and the Warburg effect by modulating the miR‐338‐3p‐PKLR axis in hepatocellular carcinoma

  2015cites this paper
• Pharmacological treatment of aldosterone excess.

  2015cites this paper
• Mineralocorticoid Receptors in the Pathophysiology of Vascular Inflammation and Atherosclerosis

  2015cites this paper
• The brain mineralocorticoid receptor and stress resilience.

  2015cites this paper
• Emerging Roles of the Mineralocorticoid Receptor in Pathology: Toward New Paradigms in Clinical Pharmacology

  2015cites this paper
• GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cells

  2015cites this paper
• Non renal effects of aldosterone.

  2014cites this paper
• 3 Brain mineralocorticoid receptors in cognition and cardiovascular

  2014cites this paper
• Brain mineralocorticoid receptors in cognition and cardiovascular homeostasis.

  2014cites this paper